Skip to main content
Signal8

Matthews Judith M.

SEC insider (Form 3/4/5 filer). CIK 0001734033. Chief Financial Officer at Eton Pharmaceuticals, Inc. (ETON). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 31, 2026. Located in DEERPARK, IL.

Companies Matthews Judith M. has filed insider reports for

  • Eton Pharmaceuticals, Inc. (ETON): Officer, Chief Financial Officer
Matthews Judith M. profile photo

Matthews Judith M.

CIK: 0001734033

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Eton Pharmaceuticals, Inc. logo
ETON

Eton Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Eton Pharmaceuticals, Inc. logo
    ETON

    Eton Pharmaceuticals, Inc.

    Jul 31, 2026
    Award

    Common Stock

    Direct
    32.2K shares-

1-1 of 1